IG Insider Trading Activity and SEC Form 4 Filings
IG insider trading summary
No open-market insider purchases or sales of Igi Laboratories, Inc (IG) have been reported on SEC Form 4 in the past 12 months.
Latest IG insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 1, 2015 | Jason Grenfell-Gardner | President & CEO | Sell | $668K (84,048 @ $7.94) |
| Apr 30, 2015 | James C Gale | Director | Buy | $101K (20,000 @ $5.04) |
| Apr 30, 2015 | James C Gale | Director | Buy | $50K (10,000 @ $5.04) |
| Mar 5, 2015 | James C Gale | Insider | Sell | $16.9M (1,696,320 @ $9.95) |
| Mar 5, 2015 | Life Sciences Opportunities Fund Instittutional II LP | Insider | Sell | $16.9M (1,696,320 @ $9.95) |
| Mar 5, 2015 | Life Sciences Opportunities Fund II LP | Insider | Sell | $3.0M (303,680 @ $9.95) |
| Mar 5, 2015 | Signet Healthcare Partners, LLC | Insider | Sell | $3.0M (303,680 @ $9.95) |
| Mar 5, 2015 | Don A Sanders | Insider | Sell | $3.0M (303,680 @ $9.95) |
| Mar 5, 2015 | Life Sciences Opportunities Fund Instittutional II LP | Insider | Sell | $3.0M (303,680 @ $9.95) |
| Mar 5, 2015 | James C Gale | Insider | Sell | $3.0M (303,680 @ $9.95) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.